| Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks? W El-Hage, C Hingray, C Lemogne, A Yrondi, P Brunault, T Bienvenu, ... L'encephale 46 (3S), S73-S80, 2020 | 426 | 2020 |
| Les professionnels de santé face à la pandémie de la maladie à coronavirus (COVID-19): quels risques pour leur santé mentale? W El-Hage, C Hingray, C Lemogne, A Yrondi, P Brunault, T Bienvenu, ... L'encephale 46 (3), S73-S80, 2020 | 370 | 2020 |
| Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review A Yrondi, M Sporer, P Peran, L Schmitt, C Arbus, A Sauvaget Brain stimulation 11 (1), 29-51, 2018 | 192 | 2018 |
| Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and … D Bennabi, T Charpeaud, A Yrondi, JB Genty, S Destouches, ... BMC psychiatry 19, 1-12, 2019 | 107 | 2019 |
| Depression and sports-related concussion: a systematic review A Yrondi, D Brauge, J LeMen, C Arbus, J Pariente La Presse Médicale 46 (10), 890-902, 2017 | 76 | 2017 |
| Psychiatric disorders and hydroxychloroquine for coronavirus disease 2019 (COVID-19): a VigiBase study P Garcia, A Revet, A Yrondi, V Rousseau, Y Degboe, F Montastruc Drug Safety 43, 1315-1322, 2020 | 52 | 2020 |
| Association between anhedonia and suicidal events in patients with mood disorders: A 3‐year prospective study D Ducasse, J Dubois, I Jaussent, JM Azorin, B Etain, S Gard, C Henry, ... Depression and anxiety 38 (1), 17-27, 2021 | 40 | 2021 |
| Structural–functional brain changes in depressed patients during and after electroconvulsive therapy A Yrondi, P Peran, A Sauvaget, L Schmitt, C Arbus Acta Neuropsychiatrica 30 (1), 17-28, 2018 | 39 | 2018 |
| Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological … D Bennabi, A Yrondi, T Charpeaud, JB Genty, S Destouches, ... BMC psychiatry 19, 1-9, 2019 | 36 | 2019 |
| Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial P Roullet, G Vaiva, E Véry, A Bourcier, A Yrondi, L Dupuch, P Lamy, ... Neuropsychopharmacology 46 (9), 1643-1649, 2021 | 35 | 2021 |
| Grey Matter changes in treatment-resistant depression during electroconvulsive therapy A Yrondi, F Nemmi, S Billoux, A Giron, M Sporer, S Taib, J Salles, D Pierre, ... Journal of affective disorders 258, 42-49, 2019 | 30 | 2019 |
| Psychiatric symptoms and quality of life in older adults with schizophrenia spectrum disorder: results from a multicenter study N Hoertel, L Rotenberg, C Blanco, R Pascal de Raykeer, C Hanon, ... European Archives of Psychiatry and Clinical Neuroscience 270, 673-688, 2020 | 29 | 2020 |
| Significant decrease in hippocampus and amygdala mean diffusivity in treatment-resistant depression patients who respond to electroconvulsive therapy A Yrondi, F Nemmi, S Billoux, A Giron, M Sporer, S Taib, J Salles, D Pierre, ... Frontiers in Psychiatry 10, 694, 2019 | 29 | 2019 |
| Childhood maltreatment and clinical severity of treatment‐resistant depression in a French cohort of outpatients (FACE‐DR): One‐year follow‐up A Yrondi, B Aouizerate, D Bennabi, R Richieri, T d'Amato, F Bellivier, ... Depression and anxiety 37 (4), 365-374, 2020 | 27 | 2020 |
| Neuroimaging biomarkers at baseline predict electroconvulsive therapy overall clinical response in depression: a systematic review A Levy, S Taib, C Arbus, P Peran, A Sauvaget, L Schmitt, A Yrondi The journal of ECT 35 (2), 77-83, 2019 | 26 | 2019 |
| Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine B Coutens, A Yrondi, C Rampon, BP Guiard Psychopharmacology 239 (9), 2735-2752, 2022 | 25 | 2022 |
| Prevalence of metabolic syndrome and associated factors in a cohort of individuals with treatment-resistant depression: results from the FACE-DR study O Godin, D Bennabi, A Yrondi, R Richieri, D Thierry, F Bellivier, ... The Journal of clinical psychiatry 80 (6), 11800, 2019 | 23 | 2019 |
| Comparative effects of 15 antidepressants on the risk of withdrawal syndrome: a real-world study using the WHO pharmacovigilance database JB Quilichini, A Revet, P Garcia, R Bouquié, J Hamard, A Yrondi, ... Journal of Affective Disorders 297, 189-193, 2022 | 20 | 2022 |
| How does repetitive transcranial magnetic stimulation influence the brain in depressive disorders?: a review of neuroimaging magnetic resonance imaging studies S Taib, C Arbus, A Sauvaget, M Sporer, L Schmitt, A Yrondi The Journal of ECT 34 (2), 79-86, 2018 | 19 | 2018 |
| Association between side effects and blood microRNA expression levels and their targeted pathways in patients with major depressive disorder treated by a selective serotonin … A Yrondi, LM Fiori, BN Frey, RW Lam, GM MacQueen, R Milev, DJ Müller, ... International Journal of Neuropsychopharmacology 23 (2), 88-95, 2020 | 17 | 2020 |
